Truist Financial Sticks to Their Hold Rating for Omega Healthcare (OHI)
In a report released today, Michael Lewis from Truist Financial maintained a Hold rating on Omega Healthcare, with a price target of $48.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Lewis is a 5-star analyst with an average return of 9.4% and a 64.34% success rate. Lewis covers the Real Estate sector, focusing on stocks such as Lineage, Inc., AvalonBay, and Safehold.
Omega Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $48.82.
Based on Omega Healthcare’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $321.82 million and a net profit of $164.72 million. In comparison, last year the company earned a revenue of $279.32 million and had a net profit of $113.34 million
Read More on OHI:
Disclaimer & DisclosureReport an Issue
- Omega Healthcare price target raised to $48 from $45 at Scotiabank
- Omega Healthcare price target raised to $47 from $44 at RBC Capital
- Omega Healthcare price target raised to $52 from $50 at Cantor Fitzgerald
- Omega Healthcare Investors: Rising Operational and Earnings Risk as RIDEA Expansion Increases Dependence on Third-Party Managers
- Omega Healthcare Investors Signals Confident 2026 Earnings Path
